A critical role for miR-184 in the fate determination of oligodendrocytes
Abstract Background New insights on cellular and molecular aspects of both oligodendrocyte (OL) differentiation and myelin synthesis pathways are potential avenues for developing a cell-based therapy for demyelinating disorders comprising multiple sclerosis. MicroRNAs (miRNA) have broad implications...
Main Authors: | Negin Afrang, Rezvan Tavakoli, Nooshin Tasharrofi, Amir Alian, Alireza Naderi Sohi, Mahboubeh Kabiri, Mehrnoosh Fathi-Roudsari, Mina Soufizomorrod, Farzad Rajaei, Masoud Soleimani, Fatemeh Kouhkan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1208-y |
Similar Items
-
Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site
by: Karl J. M. Hanf, et al.
Published: (2020-01-01) -
LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?
by: Simon Foale, et al.
Published: (2017-01-01) -
Nogo-A aggravates oxidative damage in oligodendrocytes
by: Yang-Yang Wang, et al.
Published: (2021-01-01) -
Screening for MIR184 mutations in Iranian patients with keratoconus
by: Azad Farzadfard, et al.
Published: (2016-01-01) -
A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications
by: Umesh Kathad, et al.
Published: (2021-03-01)